Prostate Cancer Clinical Trials in Houston, TX

Prostate Cancer Clinical Trials in Houston, TX

View the best 10 prostate cancer medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Prostate Cancer clinical trial.

Trials in Houston, Texas

Here are the top 10 medical studies for prostate cancer in Houston, Texas

Image of MD Anderson Cancer Center in Houston, United States.

Stereotactic Body Radiation Therapy

Radiation

Recruiting1 awardPhase 2
"This trial is studying whether a type of radiation therapy called stereotactic body radiation therapy (SBRT) is safe and effective for treating advanced or high-risk prostate cancer."
Image of JHU Sidney Kimmel Comprehensive Cancer Center LAO in Baltimore, United States.

Lutetium Lu 177 Dotatate

Radioactive Drug

Recruiting1 awardPhase 2
This trial studies how well lutetium Lu 177 dotatate works in treating patients with a specific type of prostate cancer that has spread. The drug targets cancer cells and releases radiation to kill them. Lutetium-177 (Lu-177) PSMA therapy is a targeted treatment for advanced prostate cancer that has shown promising results.
Image of Tower Urology in Los Angeles, United States.

Copper Cu 64 PSMA I&T

Cancer Imaging Agent

Recruiting2 awardsPhase 3
This trial is testing a new imaging technique using a radioactive substance called copper Cu 64 PSMA I&T injection to detect recurrent prostate cancer in patients who have previously undergone surgery or radiation therapy for prostate cancer
Image of Research Site in Detroit, United States.

Enzalutamide +3 More

Androgen Receptor Antagonist

Recruiting1 awardPhase 1 & 2
This trial tests a new drug, AZD5305, combined with hormone treatments in patients with advanced prostate cancer. It aims to see if this combination is safe and effective. The study focuses on patients whose cancer either continues to grow despite hormone therapy or is still responsive to it.
Image of VA Greater Los Angeles Healthcare System in Los Angeles, United States.

INKmune

Cancer Vaccine

Recruiting1 awardPhase 1 & 2
This trial is testing a treatment called INKmune in men with advanced prostate cancer. INKmune is given to patients through a vein in three separate doses, with at least one week in
Image of Foothills Urology in Golden, United States.

CAN-2409 Immunotherapy

Cancer Vaccine

Recruiting0 awardsPhase 2
This trial is testing CAN-2409, a treatment that kills prostate cancer cells and boosts the immune system to fight the cancer. It targets patients with localized prostate cancer. The treatment aims to improve their health outcomes by helping their immune system attack the cancer.
Image of University of Arizona Cancer Center in Phoenix, United States.

Prednisone +1 More

Corticosteroid

Recruiting0 awardsPhase 2 & 3
This trial is testing a new combination of drugs for prostate cancer that has spread and is no longer responding to hormone therapy.
Image of The Kirklin Clinic at Acton Road in Birmingham, United States.

Steroid 17alpha-monooxygenase TAK-700 +6 More

Corticosteroid

Recruiting2 awardsPhase 3
This trial is studying the use of hormone therapy, including TAK-700, together with radiation therapy to see how well it works in treating patients with prostate cancer.
Image of Mobile Infirmary Medical Center in Mobile, United States.

Intensity-Modulated Radiation Therapy (IMRT) +1 More

Radiation Therapy

Recruiting2 awardsPhase 3
This trial compares two types of radiation therapy to treat prostate cancer. Stereotactic body radiation therapy may work better than intensity-modulated radiation therapy.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Hypofractionated Radiation Therapy

Recruiting2 awardsPhase 3
This trial compares two types of radiation therapy given after surgery to treat prostate cancer. One type delivers higher doses of radiation over a shorter period of time, and the other uses lower doses given over a longer period of time. Researchers want to see which type works better.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.